StemCell Institute Inc. (7096.T)
JPY 1345.0
(1.2%)
JPY 1345.0
(1.2%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 413.75 Million JPY | 39.05% |
| 2022 | 297.56 Million JPY | 31.11% |
| 2021 | 226.95 Million JPY | 161.23% |
| 2020 | 86.87 Million JPY | -77.32% |
| 2019 | 383 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 123 Million JPY | 113.82% |
| 2023 Q2 | 126.68 Million JPY | 42.98% |
| 2023 Q4 | 57.52 Million JPY | -59.19% |
| 2023 Q3 | 140.94 Million JPY | 11.25% |
| 2023 FY | 413.75 Million JPY | 39.05% |
| 2023 Q1 | 88.6 Million JPY | 145.81% |
| 2022 Q3 | 97.62 Million JPY | 8.37% |
| 2022 FY | 297.56 Million JPY | 31.11% |
| 2022 Q4 | 36.04 Million JPY | -63.08% |
| 2022 Q2 | 90.08 Million JPY | 0.0% |
| 2021 FY | 226.95 Million JPY | 161.23% |
| 2020 FY | 86.87 Million JPY | -77.32% |
| 2019 FY | 383 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 30.673% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | 183.273% |
| GNI Group Ltd. | 13.1 Billion JPY | 96.844% |
| Linical Co., Ltd. | 725.72 Million JPY | 42.987% |
| Trans Genic Inc. | 89.43 Million JPY | -362.631% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 129.016% |
| Soiken Holdings Inc. | -610 Million JPY | 167.829% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 153.544% |
| AnGes, Inc. | -11.96 Billion JPY | 103.457% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 136.916% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 104.343% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | -296.705% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 147.866% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 137.043% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 132.786% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 151.813% |
| RaQualia Pharma Inc. | -337.36 Million JPY | 222.644% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 134.332% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 130.979% |
| PeptiDream Inc. | 6.77 Billion JPY | 93.891% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 121.438% |
| Ribomic Inc. | -1.11 Billion JPY | 137.069% |
| SanBio Company Limited | -4.53 Billion JPY | 109.116% |
| Healios K.K. | -3.37 Billion JPY | 112.245% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 135.821% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 129.692% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 129.491% |
| StemRIM | -2.07 Billion JPY | 119.931% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 66.127% |
| FunPep Company Limited | -994 Million JPY | 141.626% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 146.555% |
| Stella Pharma Corporation | -760.3 Million JPY | 154.42% |
| TMS Co., Ltd. | -943.25 Million JPY | 143.865% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 153.361% |
| Cuorips Inc. | -588.48 Million JPY | 170.309% |
| K Pharma,Inc. | 366.05 Million JPY | -13.031% |
| Takara Bio Inc. | 3 Billion JPY | 86.222% |
| ReproCELL Incorporated | -409.29 Million JPY | 201.091% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | -3640.025% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | -186.325% |
| CellSeed Inc. | -697.77 Million JPY | 159.297% |